Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Lung Neoplasms × Curcumin × Clear all

Phase

Status

Withdrawn 1 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colonic Neoplasms 2 Breast Neoplasms 2 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Lung Neoplasms 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Cachexia 1

Interventions

Cisplatin 35 Carboplatin 20 Gemcitabine 19 Radiotherapy 17 Docetaxel 17 Etoposide 16 Paclitaxel 11 Erlotinib Hydrochloride 11 Vinorelbine 9 Gefitinib 8 Drug Therapy 8 endostar protein 7 apatinib 7 Blood Specimen Collection 7 pembrolizumab 6 aumolertinib 6 Thoracic Surgery, Video-Assisted 6 osimertinib 5 durvalumab 5 Vinblastine 5 Surgical Procedures, Operative 5 Fluorodeoxyglucose F18 5 Cyclophosphamide 5 sintilimab 4 Pemetrexed 4 Hematologic Tests 4 Chemotherapy, Adjuvant 4 anlotinib 3 Tomography, X-Ray Computed 3 Radiosurgery 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02321293 2015-09-02

CURCUMIN

Lady Davis Institute

Phase 1 Unknown

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡